重症与临终关怀中的抗菌药物使用:打破沉默的帷幕
本文综合全球多学科视角,总结多国指南,结合临终无益抗菌药物使用案例,提供医患沟通临床指导,并提出改善临终抗菌药物管理的建议,以减少不当使用。
要点
- 2000至2015年全球抗菌药物消费量增加65%,2016至2023年增加16%,预计2030年前再增52%。
- 重症与临终患者中抗菌药物使用和误用仍高,尽管获益证据稀少。
- 临终抗菌药物过度使用加剧耐药,本文提出改善管理的建议。
核心结论
- 本文综合全球多学科视角,总结多国指南,结合临终无益抗菌药物使用案例,提供医患沟通指导,并提出改善临终抗菌药物管理的建议。
研究设计与样本
- 本文为观点类文章(Personal View),综合全球跨专业多学科视角,总结智利、哥伦比亚、德国、印度、马来西亚、尼日利亚、卢旺达和苏丹等多国指南,并纳入一例临终无益抗菌药物使用案例。
主要发现
- 2000至2015年全球抗菌药物消费量增加65%,2016至2023年增加16%,预计2030年前再增52%。
- 重症与临终患者中抗菌药物使用和误用仍高,尽管获益证据稀少;临终过度使用和误用进一步加剧抗菌药物耐药。
- 不同收入水平国家的实践规范和标准存在国际差异。
临床怎么用
- 本文提供关于抗菌药物治疗的患者和家属沟通的临床指导。
- 本文提出改善抗菌药物管理的建议,以动员多学科利益相关者并减少临终不当抗菌药物使用。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Global rates of antimicrobial consumption increased by 65% between 2000 and 2015, by 16% between 2016 and 2023, and are estimated to increase by an additional 52% by 2030. Antimicrobial use and misuse remains high among people with serious illness and at end of life, despite scarce evidence of benefit. In addition, the overuse and misuse of antimicrobials at end of life further exacerbate antimicrobial resistance, which is a substantial public and global health concern. This Personal View synthesises global interprofessional and multidisciplinary perspectives on antimicrobial use, stewardship, and resistance at end of life and implications at patient and population levels. Guidelines have been summarised from multiple countries, some of which offer guidance for antimicrobial use at end of life. Countries at different income levels are included (ie, Chile, Colombia, Germany, India, Malaysia, Nigeria, Rwanda, and Sudan) to show how practice norms and standards vary internationally. These examples are combined with a case of non-beneficial end-of-life antimicrobial use and clinical guidance for patient and family communication regarding antimicrobial treatment. This Personal View also provides recommendations to improve antimicrobial stewardship with the goal of engaging multidisciplinary stakeholders and decreasing inappropriate antimicrobial use at end of life.
引用
- Rosa WE, Pandey S, Wisniewski R, et al. Antimicrobials in serious illness and end-of-life care: lifting the veil of silence. Lancet Infect Dis. 2025. PMID: 40049189. doi:10.1016/S1473-3099(24)00832-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。